Design Therapeutics (DSGN) Invested Capital (2020 - 2021)
Historic Invested Capital for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $391.6 million.
- Design Therapeutics' Invested Capital changed N/A to $391.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $391.6 million, marking a year-over-year change of. This contributed to the annual value of -$11.3 million for FY2020, which is N/A changed from last year.
- According to the latest figures from Q3 2021, Design Therapeutics' Invested Capital is $391.6 million.
- In the past 5 years, Design Therapeutics' Invested Capital ranged from a high of $408.0 million in Q1 2021 and a low of -$11.3 million during Q4 2020